Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Conversation with Allergan President and CEO Brent Saunders

Brent Saunders, president and CEO of Allergan, speaks with Mark Kontos, MD, regarding recent acquisitions and the future vision of the company. By bringing in R&D assets, Allergan has been able to build a larger portfolio of product offerings for dry eye, glaucoma, and retina. As scientific and technological advances continue to emerge in ophthalmology, Mr. Saunders says that the need for R&D is still vast. He adds that the consolidation of pharmaceutical corporations allows them the ability to take greater risks with R&D to benefit customers.

Allergan


41 / 64 Series: Ophthalmology Insider


More Videos in this Series